Divalproex in Australia: Comprehensive Patient Information
Basic Product Information
- International Non-Proprietary Name (INN): Divalproex sodium
- Australia Brand Names: Epilim® (most common), Epival®
- Anatomical Therapeutic Chemical (ATC) Code: N03AG01
- Available Forms and Strengths:
- Tablets (Delayed release): 125 mg, 250 mg, 500 mg
- Enteric-coated tablets: 200 mg, 300 mg, 500 mg
- Oral solution: 200 mg/5 mL
- Sachets and extended-release formulations also available
- Manufacturers: Sanofi-Aventis, Arrow Pharmaceuticals, various generics
- Prescription Status: S4 – Prescription Only Medicine
Mechanism of Action
Simple Terms: Divalproex works by helping to balance certain chemicals in the brain, reducing the frequency and severity of seizures and stabilising mood in conditions such as bipolar disorder.
For Healthcare Professionals: Divalproex sodium (a compound of sodium valproate and valproic acid) increases brain concentrations of gamma-aminobutyric acid (GABA), an inhibitory neurotransmitter, and may block voltage-gated sodium channels. These mechanisms reduce neuronal hyperexcitability associated with seizures and modulate mood.
Pharmacokinetics
- Absorption: Well absorbed orally; peak plasma concentrations in 1–4 hours (immediate/enteric-coated) or 4–17 hours (extended release).
- Metabolism: Extensively metabolised in the liver via glucuronidation, β-oxidation, and cytochrome P450 pathway.
- Elimination: Majority excreted in urine as metabolites.
- Duration of Action: 8–24 hours depending on the formulation; suitable for once or twice daily dosing.
Use in Everyday Life and Best Practices
Divalproex is typically prescribed as a long-term treatment for epilepsy (seizure disorders), bipolar disorder, and as migraine prophylaxis. Tablets should be swallowed whole with water; do not crush or chew. Treatment should always follow the doctor's instructions, and doses should not be changed without consulting your GP or specialist. It’s important to take divalproex regularly at the same time each day for consistent effects.
- Typical adult dose: Usually starts low (e.g., 250 mg 2–3 times daily), titrated to response.
- Paediatric dose: Based on weight and clinical condition; specialist guidance is necessary.
- Missed dose: Take as soon as remembered, unless it’s almost time for the next dose. Do not double the dose.
Dosing in the Morning vs Evening
- Morning dosing: May improve adherence for some, particularly school-aged children or those who forget evening doses.
- Evening dosing: May reduce daytime side effects such as drowsiness.
- Advice: Take at consistent times with relation to meals; extended-release forms may be preferable for once-daily dosing. Discuss with your pharmacist or prescriber for an individualised dosing schedule.
Taking with Food or on an Empty Stomach
- Divalproex may be taken with or after food to minimise digestive upset (nausea/indigestion).
- Food has minimal effect on absorption, but regular meals (as typical in an Australian diet) can help with adherence and reduce side effects.
- Avoid alcohol and excessive caffeine with dosing.
Interaction Warnings
| Interaction Type | Substances | Advice |
|---|---|---|
| Food | High-fat meals | May delay absorption; generally not significant, can take with meals to reduce stomach upset |
| Alcohol | Beer, wine, spirits | Avoid – increases risk of sedation and liver effects |
| Medications | Antiepileptics (carbamazepine, phenytoin), anticoagulants (warfarin), antidepressants, aspirin, antipsychotics, HIV antivirals | May alter effect or toxicity – pharmacist/GP review is required |
| Herbal/OTC | St. John's Wort, valerian, high-dose supplements | Possible interactions – discuss with pharmacist |
Indications
| Indication | Official / Off-Label | Notes |
|---|---|---|
| Epilepsy (all forms) | Official (TGA approved) | First-line in generalised epilepsy; adjunct in partial seizures |
| Bipolar disorder (manic episodes) | Official | Control acute mania, maintenance (not depression) |
| Migraine prophylaxis | Official | For patients with frequent, disabling migraine |
| Other psychiatric disorders, neuropathic pain, aggressive behaviour | Off-label | Specialist prescribing, not TGA-approved |
Dosing According to Clinical Indications
| Population | Indication | Initial Dose | Maintenance Dose (typical) | Maximum Dose |
|---|---|---|---|---|
| Adult | Epilepsy | 250 mg 2–3 times daily | 500–2,000 mg/day (in divided doses) | 3,000 mg/day |
| Adult | Bipolar Mania | 750 mg once daily | 1,000–2,000 mg/day | 2,500 mg/day |
| Paediatric (>20 kg) | Epilepsy | 10–15 mg/kg/day | Up to 30 mg/kg/day (max 2,500 mg/day) | 60 mg/kg/day (specialist) |
| Elderly | Any indication | Start lower (125–250 mg/day) | Individual adjustment; monitor for sedation | – |
Safety Profile / Side Effects
- Common: Nausea, tremor, sleepiness, weight gain, hair thinning, dizziness
- Occasional: Mood changes, double/blurred vision, diarrhoea, increased appetite
- Rare but serious (seek urgent help):
- Severe liver injury (jaundice, abdominal pain, vomiting)
- Pancreatitis (severe abdominal pain, vomiting)
- Severe skin reactions (rash, blistering)
- Blood disorders (unusual bruising/bleeding)
- Teratogenicity (major birth defects if taken in pregnancy)
- Monitoring: Routine blood tests (liver, blood, sodium) – check regularly with your doctor
- Contraindications: Known allergy, women and girls of childbearing age unless no alternatives, significant liver disease, mitochondrial disorders
Guidelines for Proper Use
- Always follow your doctor’s instructions and consult before making changes to the dose or stopping treatment.
- Women of childbearing potential: Divalproex can severely harm an unborn baby. Effective contraception and regular review required; discuss plans for pregnancy immediately with the prescriber.
- Do not share your medication with others, even if symptoms seem similar.
- If you feel unwell, develop yellow skin/eyes, easy bruising, rash, or severe abdominal pain, seek immediate medical attention.
- Medicines and poisons in Australia are closely regulated by the TGA; always buy from reputable pharmacies.
- Avoid abrupt discontinuation; withdrawal should be gradual and supervised.
Alternative Treatment Options
- For epilepsy: Carbamazepine, lamotrigine, levetiracetam, phenytoin, topiramate
- For bipolar disorder: Lithium, lamotrigine, atypical antipsychotics (e.g., quetiapine, olanzapine, aripiprazole)
- For migraine prophylaxis: Topiramate, propranolol, amitriptyline
Comparative overview: Lithium is considered gold standard for bipolar disorder, but not for epilepsy/migraine. Lamotrigine may cause rashes and requires slow titration. Levetiracetam is usually better tolerated in elderly. Topiramate may cause cognitive effects. All options have distinct side effect profiles and efficacy for individual patients. The Pharmaceutical Benefits Scheme (PBS) reimburses most alternatives when prescribed within guidelines.
Legal, Registration, and Reimbursement Status in Australia
- Registered with: Therapeutic Goods Administration (TGA)
- PBS status: Divalproex and sodium valproate are subsidised for epilepsy, bipolar disorder, and migraine under PBS criteria
- Prescription category: S4 (must be prescribed by authorised health professional)
- Dispensing: Only at registered pharmacies; personal import limited and regulatory approval required
Latest Research/Clinical Guidance (2022–2025)
- The Royal Australian and New Zealand College of Psychiatrists (RANZCP) 2022 guidelines continue to endorse divalproex for acute mania, but recommend careful use in reproductive-age women due to teratogenicity (Australian & New Zealand Journal of Psychiatry, 2022).
- A 2023 Cochrane Review affirmed valproate’s superiority over placebo in generalised epilepsy, with similar efficacy to other first-line drugs but higher teratogenic risk in women (Cochrane Database Syst Rev, 2023).
- The Australian Therapeutic Guidelines: Neurology (2023) stress the need for baseline and ongoing liver function and blood monitoring, and avoidance in children under 2 unless essential.
Emerging evidence (2022–2024, BMJ Open) suggests extended-release forms offer better tolerability and convenience for some patients.
Availability and Delivery
| Product & Pack Size | Indicative PBS Price* | Usual Pharmacy Supply | Delivery Time Estimates (Business Days) |
|---|---|---|---|
| Epilim 200 mg tabs, 100s | $15.50 (concession), $40.10 (general) | Widely available |
|
| Epilim 500 mg tabs, 100s | $19.60 (concession), $44.60 (general) | Commonly stocked | Same as above |
| Divalproex ER 250 mg, 30s | $14.80 (concession), $37.80 (general) | Special order at some pharmacies | May require 1–2 extra days |
*Prices as of Q2/2024; check PBS or pharmacy for latest updates. Delivery estimates for web/mail orders; click and collect available.
Frequently Asked Questions (FAQ)
- Can I take Divalproex if I’m pregnant or planning a pregnancy?
Divalproex can cause serious birth defects and should not be used in pregnancy unless there is no alternative. Women of childbearing age must use effective contraception and should discuss family planning with their doctor and pharmacist as soon as possible. - What should I do if I miss a dose?
Take the missed dose as soon as you remember, unless it’s nearly time for your next dose. Never take a double dose. If unsure, consult your pharmacist or GP. - Can Divalproex interact with common painkillers, cold medicines, or supplements?
Yes. Always check with the pharmacist before using any new medication or supplement. Certain painkillers and over-the-counter (OTC) medicines can interact with Divalproex. - Do I need regular blood tests while taking Divalproex?
Yes. Regular blood tests are required to monitor liver function, blood count, and medication levels as advised by your treating doctor. - What lifestyle changes can help with my treatment?
Maintain regular sleep and meal patterns, avoid excessive alcohol, monitor mood/side effects, and keep all medical appointments—your pharmacist and doctor are key partners in your ongoing care.
